Thailand's FDA Pledge Could Cover Devices Made Outside America · Traverse Analysis
Thailand's FDA Pledge Could Cover Devices Made Outside America
Thailand's FDA recognition pledge could cover foreign-made medical devices. Final eligibility turns on the documents and manufacturing scope Thailand accepts.
Thailand's proposed recognition of U.S. Food and Drug Administration documents could matter to factories well beyond the United States. FDA can certify certain foreign-made devices shipped directly between foreign countries. The unresolved question in the U.S.-Thailand trade talks is whether those products would receive the promised Thai regulatory treatment.
For a U.S. device company's Asia regulatory-affairs lead, the immediate decision is how to prepare the Thai registration dossier. Keep the device's FDA status, manufacturing site and shipment route distinct. Possession of an FDA certificate alone does not establish U.S. manufacture, and the framework does not specify a manufacturing condition for devices. Equally, a foreign factory should not be excluded from the commercial assessment merely because the proposed concession is described as access for U.S. exports.
The framework uses different tests for vehicles and devices
The October 2025 framework puts two recognition commitments in the same paragraph on non-tariff barriers. Its vehicle language expressly refers to U.S.-manufactured vehicles that meet U.S. federal standards. The medical-device language instead identifies FDA certificates and prior marketing authorizations as evidence Thailand would accept as sufficient for its requirements.
The drafting difference leaves room for interpretation. The paragraph introduces the measures as addressing barriers to U.S. exports, and the framework leaves negotiation and domestic formalities ahead. The device clause alone cannot establish that products from every foreign factory will receive the promised treatment.
Without further evidence, a manufacturer cannot assume that the vehicle restriction also applies to medical devices. A geographical limitation and recognition of a regulator's decision are different ways to define the beneficiaries. The implementing terms must show how the two relate for devices.
An FDA certificate can follow a foreign-made device
FDA describes an export certificate as information about a product's U.S. regulatory or marketing status. Its Certificate to Foreign Government for Device Not Exported from the United States, or CFG-NE, demonstrates the geographical distinction particularly clearly.
FDA can issue a CFG-NE for devices manufactured outside the United States and shipped to another foreign country. Eligibility is conditional. Establishments appearing on the certificate must be registered and their devices listed. The devices must be lawfully marketable in the United States, including through an applicable premarket exemption, and imported or offered for import there. Devices subject to an open FDA import alert, recall or other enforcement action are ineligible. FDA also requires identification of the manufacturers and substantial compliance with current good manufacturing practice requirements. This is not a certificate available to any overseas product carrying an American brand.
The answer would determine which products a company could put forward. If Thailand accepts this category without a separate manufacturing restriction, the recognition benefit could attach to a qualifying product made abroad. If Thailand limits the concession to U.S.-manufactured devices or specified export routes, the same FDA status would be insufficient.
The registration dossier must preserve the distinction
A registration team can prepare for that decision by separating the evidence it already holds from the Thai acceptance terms it still needs. These are dossier questions, not new eligibility rules.
Evidence in the dossier
What it addresses
What remains to be established
FDA marketing-status record and applicable certificate
U.S. regulatory status and the identified product
Acceptance of that evidence under the operative Thai measure
CFG-NE and its supporting records
Conditional FDA certification for a device manufactured and shipped outside the United States
Whether Thailand includes this certificate category and supply route
Manufacturing-site and shipment records
Where the device is made and how it reaches Thailand
Any manufacturing or origin condition imposed by the final arrangement
Thai establishment and product records
The local registration pathway and applicant
Which existing requirements the new measure changes
For each device, retain the model, intended use and manufacturing-site information alongside the relevant FDA record. A certificate for one product configuration should not become a catalogue-wide assumption. Recording the actual route also makes it possible to distinguish a shipment from the United States from a foreign-made device that has U.S. marketing status but moves directly to Thailand.
That separation lets the company identify applications that might benefit when Thailand defines the recognition route. It gives no basis yet for promising a shorter registration timetable or changing a manufacturing plan.
Thai registration remains the operative starting point
Recognition can therefore change the weight given to a foreign regulator's work without necessarily removing the local applicant or every product requirement. The existing instructions are the baseline against which to measure the trade concession. They should not be treated as evidence that the promised concession already exists.
Traverse's earlier examination of reported progress in the 2027 National Trade Estimate process distinguished negotiating movement from implemented market access. The device question goes further. Even an implemented recognition promise must define whose evidence counts, for which products, and subject to which geographical conditions.
The next useful document is the Thai implementing instrument or authoritative instruction identifying accepted FDA documents, covered products, remaining registration requirements and the effective date. Explicit inclusion of CFG-NE would support assessing qualifying foreign-made devices under that route, subject to any additional conditions. A U.S.-manufacturing restriction would narrow the eligible catalogue even when FDA status is identical. Until that scope is clear, the company should prepare the evidence for recognition while keeping each application on its established Thai filing pathway.
Daily Trade Brief
Get the next one in your inbox.
New U.S. trade actions and the analysis that changes an import, customs, or counsel file, on weekday mornings after you confirm your address.
From reading to review
Run the numbers on your lane.
The duty calculator runs the current stack for any HTS code and origin. A free account opens full tool output, AD/CVD detail, Chapter 98 processing, and available exports.